Celiac Disease Treatment Market Trends, Growth Drivers, Demand, Challenges and Future Outlook

Celiac Disease Treatment Market Growth, Size, Trends Analysis - By Treatment, By Route of Administration, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Q: How can I get a sample report on the Celiac Disease Treatment Market?

You can get the sample pages by clicking the link - Click Here

Published: Jan-2025	Report ID: HLCA2534	Pages: 1 - 225	Formats^*:
Category : Healthcare

Celiac Disease Treatment Market Introduction and Overview

According to SPER Market Research, the Global Celiac Disease Treatment Market is estimated to reach USD 2044.24 million by 2034 with a CAGR of 12.09%.

The report includes an in-depth analysis of the Global Celiac Disease Treatment Market, including market size and trends, product mix, Applications, and supplier analysis. The rising number of diagnosed cases is the reason for this increase, which has raised the need for efficient therapies and diagnostic techniques. People are seeking medical attention more frequently as a result of increased public knowledge of celiac disease symptoms and the value of early diagnosis. Additionally, the growing market is supported by the variety of dietary options offered by the gluten-free food business. Improvements in disease identification and management brought about by continuous research into novel treatment modalities and advancements in diagnostic technologies further support market expansion.

By Treatment: Vitamins and minerals dominated the market in 2024, driven by the need for supplementation in individuals with celiac disease, who often face nutrient deficiencies due to malabsorption. Specialized supplements designed for celiac patients have expanded treatment options and increased awareness of the importance of proper nutrition. The demand for gluten-free products is also growing, as more people with celiac disease and other food allergies seek gluten-free diets, further fueled by health and wellness trends.

By Distribution Channel: In 2024, The oral route led the market, accounting for the largest share, as orally consumable medicines effectively manage celiac disease, control symptoms, and reduce inflammation. This includes gluten-free products, prescription medications, and supplements essential for managing the disease. Pharmaceutical companies are investing in R&D to develop new oral treatments, driving market growth during the forecast period.

By Distribution Channel: In 2024, hospitals dominated the market with the highest revenue share because of the aging population, the rise in celiac disease, and the growing need for better healthcare. Hospitals are essential for the diagnosis, management, and treatment of celiac disease. They serve as major diagnostic centers, verifying the ailment, delivering nutritional therapy, continuing monitoring, and expert advice on treatment choices such as gluten-free meals.

By Regional Insights: North America led the global celiac disease treatment market, driven by the increasing prevalence of the condition, heightened awareness, the presence of major companies, and a robust medication supply chain. The growing consumption of gluten-containing foods has contributed to higher disease rates, prompting a need for advanced diagnosis and improved treatment options.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape:

Amgen Inc., Amneal Pharmaceuticals LLC, BioLineRx Ltd., Glenmark Life Sciences Limited, Hikma Pharmaceuticals PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Tangshan UMG Medical Instrument Co., Ltd., Viatris Inc., and others.

Recent Developments:

The FDA approved Novartis' Xolair (omalizumab) in February 2024, making it the first and only drug to reduce allergic responses in people with IgE-mediated food allergies who are one year of age or older. The successful Phase III OUtMATCH research, which showed that Xolair greatly aids patients in tolerating trace levels of allergens including milk and peanuts, preceded this approval.

Scope of the Report:

Report Metric	Details
Market size available for years	2021-2034
Base year considered	2024
Forecast period	2025-2034
Segments covered	By Treatment, By Route of Administration, By Distribution Channel.
Regions covered	North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
Companies Covered	Amgen Inc., Amneal Pharmaceuticals LLC, BioLineRx Ltd., Glenmark Life Sciences Limited, Hikma Pharmaceuticals PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Tangshan UMG Medical Instrument Co., Ltd., Viatris Inc., and others.

Key Topics Covered in the Report:

Global Celiac Disease Treatment Market Size (FYâ€™2021-FYâ€™2034)
Overview of Global Celiac Disease Treatment Market
Segmentation of Global Celiac Disease Treatment Market By Treatment (Vitamins & Minerals, Gluten-free Diet, Medical Therapies)
Segmentation of Global Celiac Disease Treatment Market By Route of Administration (Oral, Parenteral)
Segmentation of Global Celiac Disease Treatment Market By Distribution Channel, (Hospitals, Research Centers, Others)
Statistical Snap of Global Celiac Disease Treatment Market
Expansion Analysis of Global Celiac Disease Treatment Market
Problems and Obstacles in Global Celiac Disease Treatment Market
Competitive Landscape in the Global Celiac Disease Treatment Market
Details on Current Investment in Global Celiac Disease Treatment Market
Competitive Analysis of Global Celiac Disease Treatment Market
Prominent Players in the Global Celiac Disease Treatment Market
SWOT Analysis of Global Celiac Disease Treatment Market
Global Celiac Disease Treatment Market Future Outlook and Projections (FYâ€™2025-FYâ€™2034)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape

5.3. PORTERs Five Forces

5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Celiac Disease Treatment Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Celiac Disease Treatment Market

7. Global Celiac Disease Treatment Market, By Treatment, (USD Million) 2021-2034

7.1. Vitamins & Minerals
7.2. Gluten-free Diet
7.3. Medical Therapies

7.3.1. Infliximab
7.3.2. Larazotide Acetate
7.3.3. Azathioprine
7.3.4. Budesonide
7.3.5. Others

8. Global Celiac Disease Treatment Market, By Route of Administration, (USD Million) 2021-2034

8.1. Oral
8.2. Parenteral

9. Global Celiac Disease Treatment Market, By Distribution Channel, (USD Million) 2021-2034

9.1. Hospitals
9.2. Research Centers
9.3. Others

10. Global Celiac Disease Treatment Market, (USD Million) 2021-2034

10.1. Global Celiac Disease Treatment Market Size and Market Share

11. Global Celiac Disease Treatment Market, By Region, (USD Million) 2021-2034

11.1. Asia-Pacific

11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific

11.2. Europe

11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe

11.3. Middle East and Africa

11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa

11.4. North America

11.4.1. Canada
11.4.2. Mexico
11.4.3. United States

11.5. Latin America

11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America

12. Company Profile

12.1. Amgen Inc.

12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments

12.2. Amneal Pharmaceuticals LLC.

12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments

12.3. BioLineRx Ltd.

12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments

12.4. Glenmark Life Sciences Limited

12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments

12.5. Hikma Pharmaceuticals PLC

12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments

12.6. Novartis AG

12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments

12.7. Takeda Pharmaceutical Company Limited.

12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments

12.8. Teva Pharmaceutical Industries Ltd.

12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments

12.9. Tangshan UMG Medical Instrument Co., Ltd.

12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments

12.10. Viatris Inc.

12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments

12.11. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the Celiac Disease Treatment Market?

Celiac Disease Treatment Market is projected to reach USD 2044.24 million by 2034, growing at a CAGR of 12.09% during the forecast period.

What is the growth rate of the Celiac Disease Treatment Market?

Celiac Disease Treatment Market grew in Market size from 2025. The Market is expected to reach USD 2044.24 million by 2034, at a CAGR of 12.09% during the forecast period.

What is the anticipated CAGR of the Celiac Disease Treatment Market?

Celiac Disease Treatment Market CAGR of 12.09% during the forecast period.

How can I get a sample report on the Celiac Disease Treatment Market?

You can get the sample pages by clicking the link - Click Here

What is the Market size of the Celiac Disease Treatment Market?

Celiac Disease Treatment Market size is USD 2044.24 million from 2025 to 2034.

Which segment is expected to Celiac Disease Treatment Market?

Celiac Disease Treatment Market is covered By Treatment, By Route of Administration, By Distribution Channel.

Which region is expected to have the highest Market share in the Celiac Disease Treatment Market?

The North America is anticipated to have the highest Market share in the Celiac Disease Treatment Market.

Who are the key players in Celiac Disease Treatment Market?

The key players in the Market include Companies Covered Amgen Inc., Amneal Pharmaceuticals LLC, BioLineRx Ltd., Glenmark Life Sciences Limited, Hikma Pharmaceuticals PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Tangshan UMG Medical Instrument Co., Ltd., Viatris Inc., and others.

What is the conclusion of the Celiac Disease Treatment Market?

People are seeking medical attention more frequently as a result of increased public knowledge of celiac disease symptoms and the value of early diagnosis.